BRAX — Braxia Scientific Share Price
0.000.00%
Last trade - 00:00- CA$1.32m
- CA$1.83m
- CA$1.88m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7248.88% | ||
| Return on Equity | -254.58% | ||
| Operating Margin | -442.97% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | 0 | 1.01 | 1.49 | 1.88 | n/a | n/a | 1977.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 26th, 2019
- Public Since
- February 27th, 2020
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 263,708,939
- Address
- 2300 - 1177 West Hastings Street, VANCOUVER, V6E2K3
- Web
- https://braxiascientific.com/
- Phone
- +1 6045259409
- Auditors
- DALE MATHESON CARR-HILTON LABONTE LLP
Upcoming Events for BRAX
Q1 2025 Braxia Scientific Corp Earnings Release
Similar to BRAX
4Front Ventures
Canadian Securities Exchange
Ascend Wellness Holdings
Canadian Securities Exchange
Atlas Global Brands
Canadian Securities Exchange
Ayr Wellness
Canadian Securities Exchange
Cansortium
Canadian Securities Exchange
FAQ
What is the Braxia Scientific share price?
As of Today at 19:04 UTC, shares in Braxia Scientific are trading at CA$0.01. This share price information is delayed by 15 minutes.
How has the Braxia Scientific share price performed this year?
Shares in Braxia Scientific last closed at CA$0.01 and the price had moved by -80% over the past 365 days. In terms of relative price strength the Braxia Scientific share price has underperformed the Toronto Stock Exchange 300 Composite Index by -81.02% over the past year.
What are the analyst and broker recommendations for Braxia Scientific?
There is no consensus recommendation for this security.
What is the Braxia Scientific dividend yield?
Braxia Scientific does not currently pay a dividend.
Does Braxia Scientific pay a dividend?
Braxia Scientific does not currently pay a dividend.
When does Braxia Scientific next pay dividends?
Braxia Scientific does not currently pay a dividend.
How do I buy Braxia Scientific shares?
To buy shares in Braxia Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Braxia Scientific?
As of the previous close price of CA$0.01, shares in Braxia Scientific had a market capitalisation of CA$1.32m.
Where are Braxia Scientific shares listed?
Here are the trading details for Braxia Scientific:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: BRAX
What kind of share is Braxia Scientific?
Based on an overall assessment of its quality, value and momentum Braxia Scientific is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Braxia Scientific share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Braxia Scientific share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Braxia Scientific. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -70.89%.
As of the last closing price of CA$0.01, shares in Braxia Scientific were trading -63.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Braxia Scientific PE Ratio?
The Braxia Scientific PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Braxia Scientific?
We do not have data on Braxia Scientific's directors